Myxobacteria are unique gram-negative bacteria characterized by the gliding nature and forming fruiting bodies upon starvation. They were not yet intensively studied because of the difficulties in their isolation and cultivation. However, myxobacteria have recently been recognized as a new and rich source of secondary metabolites which produce novel lead compounds, such as well known anticancer compounds, epothilons.
Myxobacteria are unique gram-negative bacteria characterized by the gliding nature and forming fruiting bodies upon starvation. They were not yet intensively studied because of the difficulties in their isolation and cultivation. However, myxobacteria have recently been recognized as a new and rich source of secondary metabolites which produce novel lead compounds, such as well known anticancer compounds, epothilons. 1, 2 In the course of our continuing search for novel secondary metabolites from myxobacteria, the myxobacterium Sorangium cellulosum JW1059 was found to produce a new indole alkaloid, named soraphinol A (1), along with a known compound kurasoin A (2). 3 Isolation and culture of the producing organism, S. cellulosum JW1059 were carried out by a general procedure that has been described elsewhere. 4 We describe here the isolation and structure elucidation of new metabolite by a combination of NMR techniques.
The bacterial cells and the adsorber resin were collected from culture broth and extracted with acetone. After partitioning the acetone extract between ethyl acetate and water, the concentrated organic phase was separated by silica gel column chromatography followed by Sephadex LH-20 chromatography to give 1 and 2. These compounds were finally purified by diode-array detected HPLC. The total yield of 1 from a 10 liter fermentation was 16 mg (1.6 mg/L). C NMR data as well as the corresponding proton signals at δ 7.6-6.6 in the 1 H NMR data ( Table 1 ). The UV spectrum also suggested the presence of an indole moiety in 1. A combination of with the consideration of unit formula, established the partial structure of 3-hydroxy-2-butanone. Long range couplings between isolated methylene protons (δ 3.61, 3.56) and phenyl carbons at δ 126.2 (C-1') and 131.9 (C-2', C-6') in the gHMBC data located a 4'-hydroxyphenyl moiety at C-1 of 3-hydroxy-2-butanone. Similary, long-range correlation of H-4 methylene protons (δ 3.18, 3.08) with indole carbons at 124.8 (C-2'') and 111.1 (C-3'') established a linkage between C-4 of 3-hydroxy-2-butanone moiety and C-3'' of the indole (Table 1) . Thus, the structure of compound 1 was established as 3-hydroxy-4-(3-indolyl)-1-(p-hydroxyphenyl)-2-butanone. A literature survey revealed that the optical rotation and NMR data of 1 were very similar to those of kurosoin B (3), 3 produced by a fungus Paecilomyces sp., except for a new hydroxyl group on C-4'. Although the stereochemical Kurasoins A (2) and B (3) proved to inhibit protein farnesyl transferase (PFTase) in a dose-dependent manner. The IC 50 values of these compounds against PFTase were 15.1 and 16.4 μg/mL, respectively. 5 On the basis of this information, 1 was evaluated for the PFTase inhibitor, conducted by the scintillation proximity assay. Unfortunately, soraphinol A (1) did not inhibit PFTase at concentration up to 100 μg/mL. Detailed investigation on other biological activities are now underway.
Experimental Section
General Methods. Optical rotation was measured on a JASCO P-1020 polarimeter, UV spectrum was recorded on a Agilent 8453 spectrophotometer and IR spectrum on a Bruker IFS-66/S FTIR spectrometer. ESIMS was obtained on a Agilent 1100LC/MSD trap SL mass spectrometer and HRESIMS was obtained on a high resolution tandem mass spectrometer (JMS-HX110/110A). NMR spectra were measured on a Varian UNITY 500 spectrometer working at 500 MHz for proton and 125 MHz for carbon. The 
